Dr. Aimen Arij
What Is the Potential Role of Cagrilintide and Semaglutide Therapy Combo in Obesity-Related Liver Disease?
The question of whether cagrilintide and semaglutide for fatty liver disease represents a meaningful research direction sits at the intersection of two…
How Does Tirzepatide Impact Cardiometabolic Health Outcomes in Clinical Research Trials?
Tirzepatide moves nearly every measurable driver of cardiometabolic risk in the right direction: blood glucose, body weight, blood pressure, lipids and inflammatory…
How BPC-157 Influences Inflammation and Mucosal Repair in IBD Models?
Short answer: in rodent models of colitis and gut injury, BPC-157 reliably reduced inflammation and sped up healing of the intestinal lining.…
How TB-500 Affects Cytoskeletal Regulation and Stem Cell Migration in Tissue Repair?
The title asks how TB-500 affects cytoskeletal regulation and stem cell migration in tissue repair — a phrasing that quietly assumes three…
Can PT-141 Improve Autonomic Arousal Deficits in Neurological Sexual Disorders?
Short answer: no. PT-141 (bremelanotide) has not been shown to correct autonomic arousal deficits caused by neurological disease. Its single approval —…
AOD-9604 for Fat Loss: What the Human Trials Found
AOD-9604 was engineered to isolate the fat-burning signal of growth hormone, and in its decisive human trial it failed. A 12-week phase…
How Does AOD-9604 Peptide Work in Lipolysis and Metabolic Studies?
Short answer: AOD-9604 has a coherent fat-burning mechanism and a disappointing human record. In rodent and cell studies the fragment increases fat…
NAD+ Depletion and Neurodegeneration: What the Research Shows (2026)
Short answer: NAD+ does fall in the ageing and diseased brain, and one pathway earns the word “mechanism” without hedging — SARM1-executed…
How Does GHK-Cu Modulate Cellular Antioxidant Defense Mechanisms at the Molecular Level?
GHK-Cu does two measurable things related to antioxidant defence, and one widely repeated claim about it is much weaker than it sounds.…
How Do Molecular Signaling Networks Drive Tesamorelin-Induced IGF-1 Elevation?
The question in the title is, refreshingly, a mechanistic one rather than a marketing one. It does not ask whether tesamorelin is…